Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases

Faciogenital dysplasia 5 (FGD5) amplification drives tumor cell proliferation, and is present in 9.5% of breast cancers. We describe FGD5 expression, assess associations between FGD5 amplification and FGD5 expression, and assess FGD5 expression in relation to proliferation and prognosis. FGD5 immuno...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Histochem Cytochem
Main Authors: Valla, Marit, Mjønes, Patricia G., Engstrøm, Monica J., Ytterhus, Borgny, Bordin, Diana L., van Loon, Barbara, Akslen, Lars A., Vatten, Lars J., Opdahl, Signe, Bofin, Anna M.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213565/
https://ncbi.nlm.nih.gov/pubmed/30052477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1369/0022155418792032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados